If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.
In a phase 3 trial, participants with higher-grade prostate cancer saw oncologic benefits from extended lymph node dissection during radical prostatectomy. Extended pelvic lymph node dissection (ePLND ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results